|
SHROOM3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.334420E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.573500E-02 |
| Normal-vs-Stage2 |
2.947600E-01 |
| Normal-vs-Stage3 |
1.889610E-01 |
| Normal-vs-Stage4 |
3.886800E-01 |
| Stage1-vs-Stage2 |
1.989970E-02 |
| Stage1-vs-Stage3 |
7.667600E-01 |
| Stage1-vs-Stage4 |
4.814400E-01 |
| Stage2-vs-Stage3 |
3.916100E-02 |
| Stage2-vs-Stage4 |
9.251900E-02 |
| Stage3-vs-Stage4 |
7.333800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.125030E-01 |
| Normal-vs-AfricanAmerican |
6.919700E-03 |
| Normal-vs-Asian |
7.414100E-02 |
| Caucasian-vs-AfricanAmerican |
4.955900E-03 |
| Caucasian-vs-Asian |
4.110600E-01 |
| AfricanAmerican-vs-Asian |
7.871900E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.681600E-01 |
| Normal-vs-Female |
5.922400E-02 |
| Male-vs-Female |
5.662100E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.981700E-02 |
| Normal-vs-Age(41-60Yrs) |
1.594000E-01 |
| Normal-vs-Age(61-80Yrs) |
8.899600E-01 |
| Normal-vs-Age(81-100Yrs) |
2.573400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.170400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.801800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.353180E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.386610E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.897360E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.265200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.706830E-01 |
| Classical-VS-Follicular |
4.13940004495572E-09 |
| Classical-VS-Other |
8.228800E-01 |
| Classical-VS-Normal |
2.703700E-03 |
| Tall-VS-Follicular |
6.218800E-03 |
| Tall-VS-Other |
7.290400E-01 |
| Tall-VS-Normal |
3.423400E-01 |
| Follicular-VS-Other |
8.156100E-02 |
| Follicular-VS-Normal |
1.071840E-02 |
| Other-VS-Normal |
5.386200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.174000E-01 |
| Normal-vs-N1 |
6.085200E-01 |
| N0-vs-N1 |
6.330600E-01 |
|
|
